Vaccine Therapy in Treating Patients With Metastatic Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Lung Cancer|Adult Soft Tissue Sarcoma|Colorectal Cancer|Bone Cancer|Ovarian Sarcoma|Melanoma|Colon Cancer|Rectal Cancer|Breast Cancer|Eye Cancer|Uterine Sarcoma
Interventions: DRUG: interleukin-2|DRUG: MAGE-12 peptide vaccine|DRUG: Montanide ISA-51
Sponsor: National Cancer Institute (NCI)